coronavirus
Learn about how COVID-19 vaccines are approved in the EU in online event with experts from the European Medicines Agency
Today (11 December), the European Medicines Agency (EMA) will hold an online event to explain the processes for the development, evaluation, approval and safety monitoring of COVID-19 vaccines in the EU, including EMA's specific role. It will also give the opportunity to the public and stakeholder groups to speak and share their needs, expectations and any concerns, that will be considered by EMA and the European medicines regulatory network in the decision-making process. The event will start at 13h CET and can be followed online.
More information is available on the new Commission website on safe and effective vaccination in the EU. In particular, learn about how vaccines work, the health benefits of vaccines, the authorization process, their long-term safety and the EU's current portfolio.
Share this article:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
-
Kazakhstan5 days agoKazakhstan cuts water use by 874 mln m³ through new technologies
-
General4 days agoSerbia’s business environment is driving its integration into the EU
-
Belgium5 days agoRecord breaking Belgian sailors making more waves
-
Gender equality5 days agoNew EU rules on pay transparency explained
